Fort Washington Investment Advisors Inc. OH boosted its position in Option Care Health, Inc. (NASDAQ:OPCH – Free Report) by 13.1% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 1,437,411 shares of the company’s stock after acquiring an additional 166,726 shares during the quarter. Fort Washington Investment Advisors Inc. OH owned 0.91% of Option Care Health worth $45,796,000 at the end of the most recent quarter.
Several other institutional investors and hedge funds also recently added to or reduced their stakes in OPCH. Royal Bank of Canada raised its holdings in shares of Option Care Health by 20.7% in the 1st quarter. Royal Bank of Canada now owns 231,161 shares of the company’s stock valued at $8,078,000 after purchasing an additional 39,661 shares in the last quarter. AQR Capital Management LLC grew its stake in shares of Option Care Health by 162.6% during the first quarter. AQR Capital Management LLC now owns 41,633 shares of the company’s stock worth $1,450,000 after purchasing an additional 25,777 shares in the last quarter. Empowered Funds LLC purchased a new position in Option Care Health in the first quarter valued at $208,000. Legal & General Group Plc increased its holdings in Option Care Health by 0.7% in the second quarter. Legal & General Group Plc now owns 283,158 shares of the company’s stock valued at $9,197,000 after buying an additional 2,092 shares during the last quarter. Finally, Prudential Financial Inc. raised its stake in Option Care Health by 32.6% in the second quarter. Prudential Financial Inc. now owns 396,158 shares of the company’s stock valued at $12,867,000 after buying an additional 97,465 shares in the last quarter. Institutional investors and hedge funds own 98.05% of the company’s stock.
Option Care Health Stock Performance
Shares of OPCH stock opened at $27.75 on Friday. The stock’s 50-day moving average is $32.77 and its two-hundred day moving average is $30.72. The company has a debt-to-equity ratio of 0.87, a quick ratio of 0.96 and a current ratio of 1.53. Option Care Health, Inc. has a 1 year low of $24.24 and a 1 year high of $36.80. The firm has a market cap of $4.34 billion, a price-to-earnings ratio of 21.68, a PEG ratio of 1.60 and a beta of 0.85.
Analyst Upgrades and Downgrades
Several research firms have recently issued reports on OPCH. Morgan Stanley upped their price objective on Option Care Health from $35.00 to $38.00 and gave the stock an “overweight” rating in a research report on Tuesday, January 13th. Truist Financial set a $40.00 target price on Option Care Health in a research report on Tuesday, January 13th. Weiss Ratings restated a “hold (c)” rating on shares of Option Care Health in a research note on Monday, December 29th. Jefferies Financial Group reaffirmed a “buy” rating and issued a $37.00 price target on shares of Option Care Health in a report on Tuesday, January 13th. Finally, National Bank Financial set a $37.00 price target on shares of Option Care Health in a research note on Tuesday, January 27th. One investment analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating and two have assigned a Hold rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $37.27.
Check Out Our Latest Stock Analysis on OPCH
About Option Care Health
Option Care Health (NASDAQ: OPCH) is a leading provider of home and alternate site infusion services in the United States. The company specializes in the administration of injectable therapies, including antibiotics, nutrition, hydration, immunoglobulin, pain management and specialty pharmaceuticals. Through its nationwide network of infusion pharmacies and nursing professionals, Option Care Health delivers customized care plans and in-home nursing visits to patients managing complex or chronic conditions outside of a hospital setting.
Option Care Health traces its current structure to the completion of its merger with BioScrip in early 2021, combining two of the industry’s most experienced home infusion businesses.
Further Reading
Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.
